Texas Biomed Advances AI Tools to Transform Drug Testing
SAN ANTONIO, Texas, April 20, 2026 Texas Biomedical Research Institute (Texas Biomed), in collaboration with the Southwest National Primate...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
SAN ANTONIO, Texas, April 20, 2026 Texas Biomedical Research Institute (Texas Biomed), in collaboration with the Southwest National Primate...
BOSTON, MA — November 18, 2025 — Emulate, Inc. has announced the launch of its next-generation Brain-Chip R1, a...
